Alzheimer's disease due to an intronic presenilin-1 (PSEN1 intron 4) mutation. A clinicopathological study

Brain

Volumn 123, Issue 5, 2000, Pages 894-907

  Janssen, J C ^a   Hall, M ^a   Fox, N C ^a   Harvey, R J ^a   Beck, J ^b   Dickinson, A ^b   Campbell, T ^b   Collinge, J ^b   Lantos, P L ^c   Cipolotti, L ^d   Stevens, J M ^d   Rossor, M N ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

Alzheimer's disease; Apolipoprotein E; Familial Alzheimer's disease; Presenilin 1

Indexed keywords

APOLIPOPROTEIN E; CHLORPROMAZINE; MEDROXYPROGESTERONE ACETATE; PHENOBARBITAL; PHENYTOIN; PRESENILIN 1; VALPROIC ACID;

ADULT; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; AUTOSOMAL DOMINANT INHERITANCE; BRAIN ATROPHY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; FEMALE; GENE MUTATION; GENOTYPE; HUMAN; HUMAN TISSUE; INTRON; MALE; MYOCLONUS; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PATHOLOGY; PEDIGREE; PRIORITY JOURNAL; PSYCHOMETRY; SEIZURE; STATISTICS; VERBAL MEMORY;

EID: 17944384483     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/123.5.894     Document Type: Article

References (58)

1. Alzheimer's Disease Collaborative Group. The structure of the presenilin I (S182) gene and identification of six novel mutations in early onset AD families. Nature Genet 1995; 11: 219-22.
2. Baumeister R, Leimer U, Zweckbronner I, Jakubek C, Grunberg J, Haass C. Human presenilin-1, but not familial Alzheimer's disease (FAD) mutants, facilitate Caenorhabditis elegans Notch signalling independently of proteolytic processing. Genes Funct 1997; 1: 149-59.
3. Baxter DM, Warrington EK. Measuring dysgraphia: a graded-difflculty spelling test. Behav Neurol 1994; 7: 107-16.
4. Bielschowsky M. Die silberimpregnation der axonzylinder. Zentralb Neurol 1902; 21: 579.
5. Bracco L, Gallato R, Grigoletto F, Lippi A, Lepore V, Bino G, et al. Factors affecting course and survival in Alzheimer's disease. Arch Neurol 1994; 51: 1213-9.
6. Clegg F, Warrington EK. Four easy memory tests for older adults. Memory 1994; 2: 167-82.
7. Cruts M, Backhovens H, Wang SY, Gassen GV, Theuns J, De Jonghe CD, et al. Molecular genetic analysis of familial early-onset Alzheimer's disease linked to chromosome 14q24.3. Hum Mol Genet 1995; 4: 2363-71.
8. Cruts M, Hendriks L, Van Broeckhoven C. The presenilin genes: a new gene family involved in Alzheimer disease pathology. [Review]. Hum Mol Genet 1996; 5 Spec No: 1449-55.
9. 42 secretion. Hum Mol Genet 1999; 8: 1529-40.
10. Duara R, Lopez-Alberola RF, Barker WW, Loewenstein DA, Zatinsky M, Eisdorfer CE, et al. A comparison of familial and sporadic Alzheimer's disease. Neurology 1993; 43: 1377-84.
11. Folstein MF, Folstein SE, McHughs PR. 'Mini mental state': a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-98.
12. Fox NC, Freeborough PA. Brain atrophy progression measured from registered serial MRI: validation and application to Alzheimer's disease. J Magn Reson Imaging 1997; 7: 1069-75.
13. Fox NC, Kennedy AM, Harvey RJ, Lantos PL, Roques PK, Collinge J, et al. Clinicopathological features of familial Alzheimer's disease associated with the M139V mutation in the presenilin 1 gene. Pedigree but not mutation specific age at onset provides evidence for a further genetic factor. Brain 1997; 120: 491-501.
14. Fox NC, Warrington EK, Seiffer AL, Agnew SK, Rossor MN. Presymptomatic cognitive deficits in individuals at risk of familial Alzheimer's disease. A longitudinal prospective study. Brain 1998; 121: 1631-9.
15. Fox NC, Scahill RI, Crum WR, Rossor MN. Correlation between rates of brain atrophy and cognitive decline in AD. Neurology 1999; 52: 1687-9.
16. Freeborough PA, Woods RP, Fox NC. Accurate registration of serial 3D MR brain images and its application to visualizing change in neurodegenerative disorders. J Comput Assist Tomogr 1996; 20: 1012-22.
17. Frommelt P, Schnabel R, Kuhne W, Nee LE, Polinsky RJ. Familial Alzheimer's disease: a large multigeneration German kindred. Alzheimer Dis Assoc Disord 1991; 5: 36-43.
18. Gomez-Isla T, Growdon WB, McNamara MJ, Nochlin D, Bird TD, Arango JC, et al. The impact of different presenilin 1 and presenilin 2 mutations on amyloid deposition, neurofibrillary changes and neuronal loss in the familial Alzheimer's disease brain: evidence for other phenotype-modifying factors. Brain 1999; 122: 1709-19.
19. Haltia M, Viitanen M, Sulkava R, Ala-Hurula V, Poyhonen M, Goldfarb L, et al. Chromosome 14-encoded Alzheimer's disease: genetic and clinicopathological description. Ann Neurol 1994; 36: 362-7.
20. Hardy J. Apolipoprotein E in the genetics and epidemiology of Alzheimer's disease. Am J Med Genet 1995; 60: 456-60.
21. Hardy J. Amyloid, the presenilins and Alzheimer's disease. [Review]. Trends Neurosci 1997; 20: 154-9.
22. Hodges JR, Patterson K. Is semantic memory consistently impaired early in the course of Alzheimer's disease? Neuroanatomical and diagnostic implications. Neuropsychologia 1995; 33: 441-59.
23. Hyman BT, Trojanowski JQ. Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease. J Neuropathol Exp Neurol 1997; 56: 1095-7.
24. Jackson M, Warrington EK. Arithmetic skills in patients with unilateral cerebral lesions. Cortex 1986; 22: 611-20.
25. Jacobs DM, Sano M, Dooneief G, Marder K, Bell KL, Stern Y. Neuropsychological detection and characterization of preclinical Alzheimer's disease. Neurology 1995; 45: 957-62.
26. Karlinsky H, Madrick E, Ridgley J, Berg JM, Becker R, Bergeron C, et al. A family with multiple instances of definite, probable and possible early-onset Alzheimer's disease. Br J Psychiatry 1991; 159: 524-30.
27. Kaskie B, Storandt M. Visuospatial deficit in dementia of the Alzheimer type. Arch Neurol 1995; 52: 422-5.
28. Kennedy AM, Newman S, McCaddon A, Ball J, Roques P, Mullan M, et al. Familial Alzheimer's disease. A pedigree with a mis-sense mutation in the amyloid precursor protein gene (amyloid precursor protein 717 valine→glycine). Brain 1993; 116: 309-24.
29. Kennedy AM, Newman SK, Frackowiak RS, Cunningham VJ, Roques P, Stevens J, et al. Chromosome 14 linked familial Alzheimer's disease: a clinico-pathological study of a single pedigree. Brain 1995; 118: 185-205.
30. Lampe TH, Bird TD, Nochlin D, Nemens E, Risse SC, Sumi SM, et al. Phenotype of chromosome 14-linked familial Alzheimer's disease in a large kindred. Ann Neurol 1994; 36: 368-78.
31. Lehtovirta M, Soininen H, Helisalmi S, Mannermaa A, Helkala EL, Hartikainen P, et al. Clinical and neuropsychological characteristics in familial and sporadic Alzheimer's disease: relation to apolipoprotein E polymorphism. Neurology 1996; 46: 413-9.
32. Levitan D, Greenwald I. Facilitation of lin-12-mediated signalling by sel-12, a Caenorhabditis elegans S182 Alzheimer's disease gene. Nature 1995; 377: 351-4.
33. Levitan D, Doyle TG, Brousseau D, Lee MK, Thinakaran G, Slunt HH, et al. Assessment of normal and mutant human presenilin function in Caenorhabditis elegans. Proc Natl Acad Sci USA 1996; 93: 14940-4.
34. Lippa CF, Fujiwara H, Mann DM, Giasson B, Baba M, Schmidt ML, et al. Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes. Am J Pathol 1998; 153: 1365-70.
35. Mann DM, Iwatsubo T, Cairns NJ, Lantos PL, Nochlin D, Sumi SM, et al. Amyloid beta protein (Abeta) deposition in chromosome 14-linked Alzheimer's disease: predominance of Abeta42(43). Ann Neurol 1996a; 40: 149-56.
36. Mann DM, Iwatsubo T, Ihara Y, Cairns NJ, Lantos PL, Bogdanovic N, et al. Predominant deposition of amyloid-beta 42(43) in plaques in cases of Alzheimer's disease and hereditary cerebral hemorrhage associated with mutations in the amyloid precursor protein gene. Am J Pathol 1996b; 148: 1257-66.
37. Mayeux R, Stern Y, Spanton S. Heterogeneity in dementia of the Alzheimer type: evidence of subgroups. Neurology 1985; 35: 453-60.
38. McKenna P, Warrington EK. The Graded Naming Test. Windsor (UK): NFER-Nelson; 1983.
39. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939-44.
40. Morris JC, McKeel DW Jr, Storandt M, Rubin EH, Price JL, Grant EA, et al. Very mild Alzheimer's disease: informant-based clinical, psychometric and pathological distinction from normal aging. Neurology 1991; 41: 469-78.
41. Mullan M, Houlden H, Crawford F, Kennedy A, Rogues P, Rossor M. Age of onset in familial early-onset Alzheimer's disease correlates with genetic aetiology. Am J Med Genet 1993; 48: 129-30.
42. Nee LE, Polinsky RJ, Eldridge R, Weingarter H, Smallberg S, Ebert M. A family with histologically confirmed Alzheimer's disease. Arch Neurol 1983; 40: 203-8.
43. Nelson HE. A modified card sorting test sensitive to frontal lobe defects. Cortex 1976; 12: 313-24.
44. Nelson HE, Willison J. The National Adult Reading Test (NART); manual. Windsor (UK): NFER-Nelson; 1991.
45. Newman SK, Warrington EK, Kennedy AM, Rossor MN. The earliest cognitive change in a person with familial Alzheimer's disease: presymptomatic neuropsychological features in a pedigree with familial Alzheimer's disease confirmed at necropsy. J Neurol, Neurosurg Psychiatry 1994; 57: 967-72.
46. Oldfleld RC, Wingfield A. Response latencies in naming objects. Q J Exp Psychol 1965; 17: 273-81.
47. Sadovnick AD, Tuokko H, Horton A, Baird PA, Beattie BL. Familial Alzheimer's disease. Can J Neurol Sci 1988; 15: 142-6.
48. Scheuner D, Eckman C, Jensen M, Song X, Citron M, Suzuki N, et al. Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nature Med 1996; 2: 864-70.
49. Selkoe DJ. Translating cell biology into therapeutic advances in Alzheimer's disease. Nature 1999; 399 (Suppl): A23-31.
50. Spreen O, Strauss E. A compendium of neuropsychological tests: administration, norms, and commentary. 2nd edn. New York, University Press; 1998.
51. Tysoe C, Whittaker J, Xuereb J, Cairns NJ, Cruts M, Van Broeckhoven C, et al. A presenilin-1 truncating mutation is present in two cases with autopsy-confirmed early-onset Alzheimer disease. Am J Hum Genet 1998; 62: 70-6.
52. Van Broeckhoven C, Backhovens H, Cruts M, Martin JJ, Crook R, Houlden H, et al. APOE genotype does not modulate age of onset in families with chromosome 14 encoded Alzheimer's disease. Neurosci Lett 1994; 169: 179-80.
53. Warrington EK. Recognition Memory Test. Manual. Windsor (UK): NFER-Nelson; 1984.
54. Warrington EK. The Camden Memory Tests. Manual. Hove (UK): Psychology Press; 1996.
55. Warrington EK, James M. The Visual Object and Space Perception Battery. Bury St. Edmunds (UK): Thames Valley Test Company; 1991.
56. Wechsler D. Wechsler Adult Intelligence Scale: Manual. New York: Psychological Corporation; 1955.
57. Wechsler D. Wechsler Adult Intelligence Scale: WAIS-R manual. New York: Psychological Corporation; 1981.
58. Weigl E. On the psychology of so-called processes of abstraction. J Abnorm Social Psychol 1941; 36: 3-33.